A Possible Therapeutic Application of the Selective Inhibitor of Urate Transporter 1, Dotinurad, for Metabolic Syndrome, Chronic Kidney Disease, and Cardiovascular Disease.
Yanai H, Adachi H, Hakoshima M, Iida S, Katsuyama H.
Cells. 2024 Mar 4;13(5):450. doi: 10.3390/cells13050450.
PMID:38474414
Uric Acid in Inflammation and the Pathogenesis of Atherosclerosis.
Kimura Y, Tsukui D, Kono H.
Int J Mol Sci. 2021 Nov 17;22(22):12394. doi: 10.3390/ijms222212394.